Article info

Download PDFPDF

Intravitreal bevacizumab improves trabeculectomy survival at 12 months: the bevacizumab in trabeculectomy study—a randomised clinical trial

Authors

  1. Correspondence to Associate Professor John A Landers, Ophthalmology, Flinders University of South Australia, Adelaide, South Australia, Australia; john.landers{at}bigpond.com
View Full Text

Citation

Landers JA, Mullany S, Craig JE
Intravitreal bevacizumab improves trabeculectomy survival at 12 months: the bevacizumab in trabeculectomy study—a randomised clinical trial

Publication history

  • Received March 11, 2023
  • Accepted May 2, 2023
  • First published August 4, 2023.
Online issue publication 
May 21, 2024

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.